Search results for "Avidity"

showing 10 items of 24 documents

Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain

2009

Adoptive transfer of T lymphocytes transduced with a T cell receptor (TCR) to impart tumor reactivity has been reported as a potential strategy to redirect immune responses to target cancer cells (Schumacher, T.N. 2002. Nat. Rev. Immunol. 2:512-519). However, the affinity of most TCRs specific for shared tumor antigens that can be isolated is usually low. Thus, strategies to increase the affinity of TCRs or the functional avidity of TCR-transduced T cells might be therapeutically beneficial. Because glycosylation affects the flexibility, movement, and interactions of surface molecules, we tested if selectively removing conserved N-glycoslyation sites in the constant regions of TCR alpha or …

CD4-Positive T-LymphocytesModels MolecularAdoptive cell transferGlycosylationCD3ImmunologyReceptors Antigen T-Cellchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayStreptamerBiologyArticleCell Line03 medical and health sciencesMice0302 clinical medicineImmune systemTetramerAntigenModelsCell Line TumorNeoplasmsReceptorsImmunology and AllergyAnimalsHumansAvidity030304 developmental biology0303 health sciencesTumorReverse Transcriptase Polymerase Chain ReactionT-cell receptorTemperatureMolecularhemic and immune systemsT-CellFlow CytometryMolecular biologyAdoptive TransferAntigenbiology.protein030215 immunologyProtein Binding
researchProduct

Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.

2009

The cancer-testis antigen NY-ESO-1 has been targeted as a tumor-associated antigen by immunotherapeutical strategies, such as cancer vaccines. The prerequisite for a T-cell-based therapy is the induction of T cells capable of recognizing the NY-ESO-1-expressing tumor cells. In this study, we generated human T lymphocytes directed against the immunodominant NY-ESO-1(157-165) epitope known to be naturally presented with HLA-A*0201. We succeeded to isolate autorestricted and allorestricted T lymphocytes with low, intermediate or high avidity TCRs against the NY-ESO-1 peptide. The avidity of the established CTL populations correlated with their capacity of lysing HLA-A2-positive, NY-ESO-1-expre…

Cancer ResearchAdoptive cell transferReceptors Antigen T-Cellchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayStreptamerBiologyEpitopeAntigenAntigens NeoplasmHLA-A2 AntigenCytotoxic T cellHumansAvidityAntigen PresentationHLA-A AntigensT-cell receptorAntibody-Dependent Cell CytotoxicityMembrane ProteinsT lymphocyteCytotoxicity Tests ImmunologicFlow CytometryPeptide FragmentsNeoplasm ProteinsGenes T-Cell ReceptorOncologyImmunologyProtein MultimerizationT-Lymphocytes CytotoxicInternational journal of cancer
researchProduct

Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool

2020

Purpose The utility of 18-fluordesoxyglucose positron emission tomography ([18F]-FDG-PET) combined with computer tomography or magnetic resonance imaging (MRI) in gastric cancer remains controversial and a rationale for patient selection is desired. This study aims to establish a preclinical patient-derived xenograft (PDX) based [18F]-FDG-PET/MRI protocol for gastric cancer and compare different PDX models regarding tumor growth and FDG uptake. Materials and methods Female BALB/c nu/nu mice were implanted orthotopically and subcutaneously with gastric cancer PDX. [18F]-FDG-PET/MRI scanning protocol evaluation included different tumor sizes, FDG doses, scanning intervals, and organ-specific …

Cancer ResearchPathologymedicine.medical_specialtyStandardized uptake value03 medical and health sciences0302 clinical medicinemedicineAviditymedicine.diagnostic_testbiologybusiness.industryXenograftGastroenterologyGlucose transporterCancerMagnetic resonance imagingPET scanmedicine.diseasecarbohydrates (lipids)OncologyPositron emission tomography030220 oncology & carcinogenesisbiology.proteinImmunohistochemistry030211 gastroenterology & hepatologyGLUT1Original ArticlebusinessGastric cancerGlycolysisJournal of Gastric Cancer
researchProduct

Revisiting CD8 T-cell ‘Memory Inflation’: New Insights with Implications for Cytomegaloviruses as Vaccine Vectors

2020

Murine models of cytomegalovirus (CMV) infection have revealed an exceptional kinetics of the immune response. After resolution of productive infection, transient contraction of the viral epitope-specific CD8 T-cell pool was found to be followed by a pool expansion specific for certain viral epitopes during non-productive &lsquo

KLRG10301 basic medicinecentral memory CD8 T cells (TCM)vaccine vectorHigh avidityImmunologylcsh:MedicineBiologyArticleEpitope03 medical and health sciences0302 clinical medicineImmune systemDrug DiscoveryCytotoxic T cellPharmacology (medical)Aviditycytomegalovirusmemory inflationPharmacologyeffector memory CD8 T cells (TEM)Human studiesEffectoravidity maturationlcsh:RVirology030104 developmental biologyInfectious Diseasesconventional TEM (cTEM)CD8inflationary TEM (iTEM)030215 immunologyVaccines
researchProduct

Absence of long-term effects of reproduction on longevity in the mouse model.

2014

Background Most human demographic data, particularly those on natural fertility populations, find no relationship or even a positive association between fertility and longevity. The present study aims to ascertain whether there is a trade-off between fertility and longevity in the mouse model. Methods The study was focused on the first litter produced by 10- to 14-wk-old hybrid (C57BL/6JIco female X CBA/JIco male) mice. A single female/male per litter was individually housed with a male/female at the age of 25 and 52 wk, respectively, until the end of reproductive life in females or natural death in males under controlled housing conditions. Post-reproductive females and virgin mice were re…

Litter (animal)MaleTrade-offsAgingOffspringmedia_common.quotation_subjectLongevityFertilityGravidityBiologyModels BiologicalEndocrinologyLife-history traitsPregnancyAnimalsGender gapParental investmentSurvival analysisreproductive and urinary physiologyCrosses Geneticmedia_commonGeneticsSex CharacteristicsSurvival timesReproductionResearchLongevityObstetrics and GynecologySurvival AnalysisMice Inbred C57BLParental investmentParityFertilityReproductive MedicinePhysiological costs of reproductionNatural fertilityMice Inbred CBAFemaleReproductionDevelopmental BiologyDemographyReproductive biology and endocrinology : RBE
researchProduct

TCR-Ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer.

2013

Adoptive immunotherapy is a promising therapeutic approach for the treatment of chronic infections and cancer. Thereby, T cells within a certain range of high avidity for their cognate ligand are believed to be most effective. T cell receptor (TCR) transfer experiments indicate that a major part of avidity is hard-wired within the structure of the TCR. Unfortunately, rapid measurement of structural avidity of TCRs is difficult on living T cells. We developed a technology, where dissociation (koff-rate) of truly monomeric peptide major histocompatibility complex (pMHC) molecules bound to surface expressed TCRs can be monitored by real-time microscopy in a highly reliable manner. A first eval…

MaleAdoptive cell transferT cellmedicine.medical_treatmentReceptors Antigen T-CellGenes MHC Class Ichemical and pharmacologic phenomenaStreptamerBiologyCD8-Positive T-LymphocytesMajor histocompatibility complexImmunotherapy AdoptiveArticleMicemedicineCytotoxic T cellAnimalsHumansAvidityCells CulturedT-cell receptorGeneral MedicineImmunotherapyAdoptive Transfermedicine.anatomical_structureImmunologybiology.proteinFemale
researchProduct

Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection

2006

A familial outbreak of human parvovirus B19 infection is described in which serological tests carried out routinely for determining the causal agent of febrile rashes of viral etiology failed to yield a definitive diagnosis. Concurrent detection of serum IgMs to parvovirus B19 and to heterologous viruses such as human herpesvirus type 6 (HHV-6) and measles virus complicated interpretation of the data. IgG avidity tests and investigation and testing for the presence of viral DNA in sera by PCR were required to confirm parvovirus B19. The study stresses the importance of avidity and PCR tests to obtain a firm diagnosis of febrile exanthematic viral diseases.

MaleHerpesvirus 6 HumanvirusesErythema InfectiosumAntibodies ViralVirusMeasles virusMorbillivirusVirologyExanthema SubitumParvovirus B19 HumanHumansAvidityChildParvoviridaebiologyParvovirusvirus diseasesbiology.organism_classificationVirologyInfectious DiseasesImmunoglobulin MMeasles virusDNA ViralImmunologyFemaleHuman herpesvirus 6Viral diseaseJournal of Medical Virology
researchProduct

RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+T CELL …

2012

HLA-B*27 exerts protective effects in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. While the immunological and virological features of HLA-B*27-mediated protection are not fully understood, there is growing evidence that the presentation of specific immunodominant HLA-B*27-restricted CD8+ T-cell epitopes contributes to this phenomenon in both infections. Indeed, protection can be linked to single immunodominant CD8+ T-cell epitopes and functional constraints on escape mutations within these epitopes. To better define the immunological mechanisms underlying HLA-B*27-mediated protection in HCV infection, we analyzed the functional avidity, functional profile, ant…

MaleProteasome Endopeptidase ComplexQH301-705.5Immune CellsAntigen presentationImmunologyAntigen-Presenting CellsAntigen Processing and RecognitionHepacivirusBiologyAdaptive ImmunityCD8-Positive T-LymphocytesMicrobiologyEpitopeImmune ActivationMajor Histocompatibility ComplexEpitopesImmune systemVirologyGeneticsCytotoxic T cellHumansAvidityBiology (General)Antigen-presenting cellMolecular BiologyBiologyAntigen PresentationLinear epitopeAntigen processingT CellsImmunityRC581-607VirologyHepatitis CHLA-B AntigensImmunologyProteolysisQR180ParasitologyFemaleImmunologic diseases. AllergyHepatitis C AntigensResearch Article
researchProduct

Probing human beta1- and beta2 -adrenoceptors with domain-specific fusion protein antibodies.

1997

In order to generate antibodies suitable for immunological studies on beta-adrenoceptors constitutively expressed at low levels in cells or tissues we have produced fusion proteins of the amino- and carboxy-terminus, and the second extracellular loop of the human beta 1- or beta 2-adrenoceptors with bacterial glutathione-S-transferase in E. coli. Rabbit antibodies raised against these fusion proteins strongly reacted with intact human beta 1- or beta 2-adrenoceptors in a subtype- and domain-specific manner. Antibodies directed against the second extracellular loop of the beta 1-adrenoceptor reacted stronger with non-denatured receptors and decreased the affinity of the 3H-labelled antagonis…

Recombinant Fusion ProteinsBlotting WesternEnzyme-Linked Immunosorbent AssayBiologyImmunofluorescenceProtein Structure SecondaryAntibodiesRadioligand AssayAntibody SpecificitymedicineExtracellularAnimalsHumansAvidityReceptorFluorescent Antibody Technique IndirectPharmacologymedicine.diagnostic_testMolecular biologyFusion proteinPrimary and secondary antibodiesPrecipitin TestsBlotMicroscopy FluorescenceBiochemistrybiology.proteinRabbitsReceptors Adrenergic beta-2AntibodyReceptors Adrenergic beta-1European journal of pharmacology
researchProduct

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2

2020

AbstractA safe and effective vaccine against COVID-19 is urgently needed in quantities sufficient to immunise large populations. We report the preclinical development of two BNT162b vaccine candidates, which contain lipid-nanoparticle (LNP) formulated nucleoside-modified mRNA encoding SARS-CoV-2 spike glycoprotein-derived immunogens. BNT162b1 encodes a soluble, secreted, trimerised receptor-binding domain (RBD-foldon). BNT162b2 encodes the full-length transmembrane spike glycoprotein, locked in its prefusion conformation (P2 S). The flexibly tethered RBDs of the RBD-foldon bind ACE2 with high avidity. Approximately 20% of the P 2S trimers are in the two-RBD ‘down,’ one-RBD ‘up’ state. In mi…

Vaccinationchemistry.chemical_classificationMessenger RNACoronavirus disease 2019 (COVID-19)chemistryHigh aviditySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyGlycoproteinVirologyCD8Transmembrane protein
researchProduct